Dronedarone: is it time to turn it down?

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.1, 2013-01, pp. : 5-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dronedarone: a done deal?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 617, 2010-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Reduction of Myocardial Infarct Size by Dronedarone in Pigs—A Pleiotropic Action?

By Skyschally Andreas

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 3, 2011-06 ,pp. : 197-201

Springer Publishing Company

Access to resources Recommend Favorite

Best value test for detecting Down's syndrome in the UK?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 328, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Which Down's syndrome screening option best in Canada?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 573, 2009-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Biomanufacturing: time for change?

By Gottschalk Uwe

Pharmaceutical Bioprocessing, Vol. 1, Iss. 1, 2013-04 ,pp. : 7-9

Future Science

Access to resources Recommend Favorite